Raymond Dwek, Director at UNITED THERAPEUTICS Corp (UTHR), sold 3,000 shares at $285.57 ($857K) on 2025-04-21, disclosed to the SEC on 2025-04-22.
Scheduled sale ($857k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2024-08-05 | $1.6M | — | Filing → |
| UTHR | SELL | 2022-07-11 | $1.0M | — | Filing → |
| UTHR | SELL | 2021-06-30 | $1.2M | — | Filing → |